In the footsteps of an inhibitor unbinding from the active site of human carbonic anhydrase II

References

• Acharya, A., Agarwal, R., Baker, M. B., Baudry, J., Bhowmik, D., Boehm, S., Byler, K. G., Chen, S. Y., Coates, L., Cooper, C. J., Demerdash, O., Daidone, I., Eblen, J. D., Ellingson, S., Forli, S., Glaser, J., Gumbart, J. C., Gunnels, J., Hernandez, O., … Zanetti-Polzi, L. (2020). Supercomputer-based ensemble docking drug discovery pipeline with application to covid-19. Journal of Chemical Information and Modeling, 60(12), 5832–5852. https://doi.org/10.1021/acs.jcim.0c01010
   PubMed Web of Science ®Google Scholar
• Alaei, L., Khodarahmi, R., Sheikh-Hasani, V., Sheibani, N., & Moosavi-Movahedi, A. A. (2018). Mechanistic investigation of sulfonamide ligands as human carbonic anhydrase II inhibitors. International Journal of Biological Macromolecules, 120(Pt A), 1198–1207.
   PubMedGoogle Scholar
• Alterio, V., Di Fiore, A., D’Ambrosio, K., Supuran, C. T., & De Simone, G. (2012). Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms? Chemical Reviews, 112(8), 4421–4468.
   PubMed Web of Science ®Google Scholar
• Al-Warhi, T., Sabt, A., Elkaeed, E. B., & Eldehna, W. M. (2020). Recent advancements of coumarin-based anticancer agents: An up-to-date review. Bioorganic Chemistry, 103, 104163.
   PubMed Web of Science ®Google Scholar
• Angeli, A., Carta, F., Nocentini, A., Winum, J.-Y., Zalubovskis, R., Akdemir, A., Onnis, V., Eldehna, W. M., Capasso, C., Simone, G. D., Monti, S. M., Carradori, S., Donald, W. A., Dedhar, S., & Supuran, C. T. (2020). Carbonic anhydrase inhibitors targeting metabolism and tumor microenvironment. Metabolites, 10(10), 412. https://doi.org/10.3390/metabo10100412
   PubMed Web of Science ®Google Scholar
• Appel, E. A., Biedermann, F., Hoogland, D., Del Barrio, J., Driscoll, M. D., Hay, S., Wales, D. J., & Scherman, O. A. (2017). Decoupled associative and dissociative processes in strong yet highly dynamic host-guest complexes. Journal of the American Chemical Society, 139(37), 12985–12993. https://doi.org/10.1021/jacs.7b04821
   PubMed Web of Science ®Google Scholar
• Bonomi, M., Branduardi, D., Bussi, G., Camilloni, C., Provasi, D., Raiteri, P., Donadio, D., Marinelli, F., Pietrucci, F., Broglia, R. A., & Parrinello, M. (2009). Plumed: A portable plugin for free-energy calculations with molecular dynamics. Computer Physics Communications, 180(10), 1961–1972. https://doi.org/10.1016/j.cpc.2009.05.011
   Web of Science ®Google Scholar
• Carta, F., Maresca, A., Scozzafava, A., & Supuran, C. T. (2012). Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII. Bioorganic & Medicinal Chemistry, 20(7), 2266–2273. https://doi.org/10.1016/j.bmc.2012.02.014
   PubMed Web of Science ®Google Scholar
• Case, D., Babin, V., Berryman, J., Betz, R., Cai, Q., Cerutti, D., Cheatham, T., Darden, T., Duke, R. E., Gohlke, H., Götz, A. W., Gusarov, S., Homeyer, N., Janowski, P. A., Kaus, J., Kolossváry, I., Kovalenko, A., Lee, T.-S., Legrand, S., Luchko, T., … Kollman, P. (2014). Amber 14. University of California.
   Google Scholar
• Chahal, V., Nirwan, S., & Kakkar, R. (2020). A comparative study of the binding modes of SLC-0111 and its analogues in the hCA II and hCA IX active sites using QM/MM, molecular docking, MM-GBSA and MD approaches. Biophysical Chemistry, 265, 106439. https://doi.org/10.1016/j.bpc.2020.106439
   PubMed Web of Science ®Google Scholar
• Chahal, V., Nirwan, S., Pathak, M., & Kakkar, R. (2020). Identification of potent human carbonic anhydrase IX inhibitors: A combination of pharmacophore modeling, 3D-QSAR, virtual screening and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 265, 1–16. https://doi.org/10.1080/07391102.2020.1860132
   Google Scholar
• Chen, G., Kong, X., Lu, D., Wu, J., & Liu, Z. (2017). Kinetics of CO2 diffusion in human carbonic anhydrase: A study using molecular dynamics simulations and the Markov-state model. Physical Chemistry Chemical Physics, 19(18), 11690–11697. https://doi.org/10.1039/C7CP00887B
   PubMed Web of Science ®Google Scholar
• Chovancova, E., Pavelka, A., Benes, P., Strnad, O., Brezovsky, J., Kozlikova, B., Gora, A., Sustr, V., Klvana, M., Medek, P., Biedermannova, L., Sochor, J., & Damborsky, J. (2012). Caver 3.0: A tool for the analysis of transport pathways in dynamic protein structures. PLoS Computational Biology, 8(10), e1002708. https://doi.org/10.1371/journal.pcbi.1002708
   PubMed Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh ewald: An n·log(n) method for ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092.
   Web of Science ®Google Scholar
• Ferraroni, M., Carta, F., Scozzafava, A., & Supuran, C. T. (2016). Thioxocoumarins show an alternative carbonic anhydrase inhibition mechanism compared to coumarins. Journal of Medicinal Chemistry, 59(1), 462–473.
   PubMed Web of Science ®Google Scholar
• Fisher, S. Z., Maupin, C. M., Budayova-Spano, M., Govindasamy, L., Tu, C., Agbandje-McKenna, M., Silverman, D. N., Voth, G. A., & McKenna, R. (2007). Atomic crystal and molecular dynamics simulation structures of human carbonic anhydrase II: Insights into the proton transfer mechanism. Biochemistry, 46(11), 2930–2937. https://doi.org/10.1021/bi062066y
   PubMed Web of Science ®Google Scholar
• Fox, J. M., Kang, K., Sastry, M., Sherman, W., Sankaran, B., Zwart, P. H., & Whitesides, G. M. (2017). Water-restructuring mutations can reverse the thermodynamic signature of ligand binding to human carbonic anhydrase. Angewandte Chemie (International ed. in English), 56(14), 3833–3837. https://doi.org/10.1002/anie.201609409
   PubMed Web of Science ®Google Scholar
• Frishman, D., & Argos, P. (1995). Knowledge-based protein secondary structure assignment. Proteins: Structure, Function, and Genetics, 23(4), 566–579. https://doi.org/10.1002/prot.340230412
   PubMed Web of Science ®Google Scholar
• Galati, S., Yonchev, D., Rodríguez-Pérez, R., Vogt, M., Tuccinardi, T., & Bajorath, J. (2021). Predicting isoform-selective carbonic anhydrase inhibitors via machine learning and rationalizing structural features important for selectivity. ACS Omega, 6(5), 4080–4089.
   PubMed Web of Science ®Google Scholar
• Gaspari, R., Rechlin, C., Heine, A., Bottegoni, G., Rocchia, W., Schwarz, D., Bomke, J., Gerber, H.-D., Klebe, G., & Cavalli, A. (2016). Kinetic and structural insights into the mechanism of binding of sulfonamides to human carbonic anhydrase by computational and experimental studies. Journal of Medicinal Chemistry, 59(9), 4245–4256. https://doi.org/10.1021/acs.jmedchem.5b01643
   PubMed Web of Science ®Google Scholar
• Glöckner, S., Heine, A., & Klebe, G. (2020). A proof-of-concept fragment screening of a hit-validated 96-compounds library against human carbonic anhydrase II. Biomolecules, 10(4), 518. https://doi.org/10.3390/biom10040518
   PubMed Web of Science ®Google Scholar
• Häkansson, K., Carlsson, M., Svensson, L., & Liljas, A. (1992). Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes. Journal of Molecular Biology, 227(4), 1192–1204.
   PubMed Web of Science ®Google Scholar
• Her, Y., Kil, M. S., Park, J. H., Kim, C. W., & Kim, S. S. (2011). Stevens–Johnson syndrome induced by acetazolamide. The Journal of Dermatology, 38(3), 272–275.
   PubMed Web of Science ®Google Scholar
• Hüfner-Wulsdorf, T., & Klebe, G. (2020). Role of water molecules in protein-ligand dissociation and selectivity discrimination: Analysis of the mechanisms and kinetics of biomolecular solvation using molecular dynamics. Journal of Chemical Information and Modeling, 60(3), 1818–1832. https://doi.org/10.1021/acs.jcim.0c00156
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38.
   PubMedGoogle Scholar
• Idrees, D., Hadianawala, M., Mahapatra, A. D., Datta, B., Roy, S., Ahamad, S., Khan, P., & Imtaiyaz Hassan, M. (2018). Implication of sulfonylurea derivatives as prospective inhibitors of human carbonic anhydrase II. International Journal of Biological Macromolecules, 115, 961–969. https://doi.org/10.1016/j.ijbiomac.2018.04.131
   PubMed Web of Science ®Google Scholar
• Izrailev, S., Stepaniants, S., Isralewitz, B., Kosztin, D., Lu, H., Molnar, F., Wriggers, W., & Schulten, K. (1999). Steered molecular dynamics. Springer.
   Google Scholar
• Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79(2), 926–935. https://doi.org/10.1063/1.445869
   Web of Science ®Google Scholar
• Kovalevsky, A., Aggarwal, M., Velazquez, H., Cuneo, M. J., Blakeley, M. P., Weiss, K. L., Smith, J. C., Fisher, S. Z., & McKenna, R. (2018). "To be or not to be" protonated: Atomic details of human carbonic anhydrase-clinical drug complexes by neutron crystallography and simulation. Structure, 26(3), 383–390. https://doi.org/10.1016/j.str.2018.01.006
   PubMed Web of Science ®Google Scholar
• Kräutler, V., Gunsteren, W. F. v., & Hünenberger, P. H. (2001). A fast shake algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. Journal of Computational Chemistry, 22(5), 501–508.
   Web of Science ®Google Scholar
• Kumar, A., Agarwal, P., Rathi, E., & Kini, S. G. (2020). Computer-aided identification of human carbonic anhydrase isoenzyme VII inhibitors as potential antiepileptic agents. Journal of Biomolecular Structure and Dynamics, 1–16.
   PubMed Web of Science ®Google Scholar
• Kumar, S., Rosenberg, J. M., Bouzida, D., Swendsen, R. H., & Kollman, P. A. (1992). The weighted histogram analysis method for free-energy calculations on biomolecules. I. The method. Journal of Computational Chemistry, 13(8), 1011–1021. https://doi.org/10.1002/jcc.540130812
   Web of Science ®Google Scholar
• Kumar, S., Rulhania, S., Jaswal, S., & Monga, V. (2021). Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors. European Journal of Medicinal Chemistry, 209, 112923.
   PubMed Web of Science ®Google Scholar
• Kurt, B. Z., Dag, A., Doğan, B., Durdagi, S., Angeli, A., Nocentini, A., Supuran, C. T., & Sonmez, F. (2019). Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma. Bioorganic Chemistry, 87, 838–850. https://doi.org/10.1016/j.bioorg.2019.03.003
   PubMed Web of Science ®Google Scholar
• Linkuvienė, V., Talibov, V. O., Danielson, U. H., & Matulis, D. (2018). Introduction of intrinsic kinetics of protein-ligand interactions and their implications for drug design. Journal of Medicinal Chemistry, 61(6), 2292–2302.
   PubMed Web of Science ®Google Scholar
• Linkuvienė, V., Zubrienė, A., Manakova, E., Petrauskas, V., Baranauskienė, L., Zakšauskas, A., Smirnov, A., Gražulis, S., Ladbury, J. E., & Matulis, D. (2018). Thermodynamic, kinetic, and structural parameterization of human carbonic anhydrase interactions toward enhanced inhibitor design. Quarterly Reviews of Biophysics, 51, e10. https://doi.org/10.1017/S0033583518000082
   PubMed Web of Science ®Google Scholar
• Loncharich, R. J., Brooks, B. R., & Pastor, R. W. (1992). Langevin dynamics of peptides: The frictional dependence of isomerization rates of N-acetylalanyl-N'-methylamide. Biopolymers, 32(5), 523–535. https://doi.org/10.1002/bip.360320508
   PubMed Web of Science ®Google Scholar
• Luchinat, E., Barbieri, L., Cremonini, M., Nocentini, A., Supuran, C. T., & Banci, L. (2020). Intracellular binding/unbinding kinetics of approved drugs to carbonic anhydrase II observed by in-cell NMR. ACS Chemical Biology, 15(10), 2792–2800.
   PubMed Web of Science ®Google Scholar
• Ma, H., Li, A., & Gao, K. (2017). Network of conformational transitions revealed by molecular dynamics simulations of the carbonic anhydrase II apo-enzyme. ACS Omega, 2(11), 8414–8420.
   PubMed Web of Science ®Google Scholar
• Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696–3713.
   PubMed Web of Science ®Google Scholar
• Mancuso, F., De Luca, L., Angeli, A., Berrino, E., Del Prete, S., Capasso, C., Supuran, C. T., & Gitto, R. (2020). In silico-guided identification of new potent inhibitors of carbonic anhydrases expressed in vibrio cholerae. ACS Medicinal Chemistry Letters, 11(11), 2294–2299. https://doi.org/10.1021/acsmedchemlett.0c00417
   PubMed Web of Science ®Google Scholar
• Maresca, A., Temperini, C., Pochet, L., Masereel, B., Scozzafava, A., & Supuran, C. T. (2010). Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. Journal of Medicinal Chemistry, 53(1), 335–344.
   PubMed Web of Science ®Google Scholar
• Matulis, D. (2019). Carbonic anhydrase as drug target: Thermodynamics and Structure of inhibitor binding. Springer International Publishing.
   Google Scholar
• Maupin, C. M., & Voth, G. A. (2010). Proton transport in carbonic anhydrase: Insights from molecular simulation. Biochimica et Biophysica Acta, 1804(2), 332–341. https://doi.org/10.1016/j.bbapap.2009.09.006
   PubMed Web of Science ®Google Scholar
• Meleddu, R., Deplano, S., Maccioni, E., Ortuso, F., Cottiglia, F., Secci, D., Onali, A., Sanna, E., Angeli, A., Angius, R., Alcaro, S., Supuran, C. T., & Distinto, S. (2021). Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry, 36(1), 685–692. https://doi.org/10.1080/14756366.2021.1887171
   PubMed Web of Science ®Google Scholar
• Melis, C., Distinto, S., Bianco, G., Meleddu, R., Cottiglia, F., Fois, B., Taverna, D., Angius, R., Alcaro, S., Ortuso, F., Gaspari, M., Angeli, A., Del Prete, S., Capasso, C., Supuran, C. T., & Maccioni, E. (2018). Targeting tumor associated carbonic anhydrases IX and XII: Highly isozyme selective coumarin and psoralen inhibitors. ACS Medicinal Chemistry Letters, 9(7), 725–729. https://doi.org/10.1021/acsmedchemlett.8b00170
   PubMed Web of Science ®Google Scholar
• Mishra, C. B., Tiwari, M., & Supuran, C. T. (2020). Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today? Medicinal Research Reviews, 40(6), 2485–2565.
   PubMed Web of Science ®Google Scholar
• Murray, A. B., Lomelino, C. L., Supuran, C. T., & McKenna, R. (2018). “Seriously sweet”: Acesulfame K exhibits selective inhibition using alternative binding modes in carbonic anhydrase isoforms. Journal of Medicinal Chemistry, 61(3), 1176–1181.
   PubMed Web of Science ®Google Scholar
• Mushtaque, M., Avecilla, F., Ahmad, I., Alharbi, A. M., Khan, P., Ahamad, S., & Hassan, M. I. (2021). 5-Fluorouracil (5-FU)-based Aza-Michael addition product: A selective carbonic anhydrase IX inhibitor. Journal of Molecular Structure, 1231, 129977. https://doi.org/10.1016/j.molstruc.2021.129977
   Web of Science ®Google Scholar
• Neophytou, C. M., Panagi, M., Stylianopoulos, T., & Papageorgis, P. (2021). The role of tumor microenvironment in cancer metastasis: Molecular mechanisms and therapeutic opportunities. Cancers, 13(9), 2053. https://doi.org/10.3390/cancers13092053
   PubMed Web of Science ®Google Scholar
• Nocentini, A., Angeli, A., Carta, F., Winum, J.-Y., Zalubovskis, R., Carradori, S., Capasso, C., Donald, W. A., & Supuran, C. T. (2021). Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. Journal of Enzyme Inhibition and Medicinal Chemistry, 36(1), 561–580. https://doi.org/10.1080/14756366.2021.1882453
   PubMed Web of Science ®Google Scholar
• Nocentini, A., & Supuran, C. T. (2019). Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. Expert Opinion on Drug Discovery, 14(11), 1175–1197.
   PubMed Web of Science ®Google Scholar
• Palermo, G., Spinello, A., Saha, A., & Magistrato, A. (2021). Frontiers of metal-coordinating drug design. Expert Opinion on Drug Discovery, 16(5), 497–511.
   PubMed Web of Science ®Google Scholar
• Paul, S., Paul, T. K., & Taraphder, S. (2018). Reaction coordinate, free energy, and rate of intramolecular proton transfer in human carbonic anhydrase II. The Journal of Physical Chemistry. B, 122(11), 2851–2866.
   PubMed Web of Science ®Google Scholar
• Paul, T. K., & Taraphder, S. (2020). Coordination dynamics of zinc triggers the rate determining proton transfer in human carbonic anhydrase II. Chemphyschem, 21(13), 1455–1473.
   PubMed Web of Science ®Google Scholar
• Peters, M. B., Yang, Y., Wang, B., Füsti-Molnár, L., Weaver, M. N., & Merz, K. M. (2010). Structural survey of zinc-containing proteins and development of the zinc AMBER force field (ZAFF). Journal of Chemical Theory and Computation, 6(9), 2935–2947.
   PubMed Web of Science ®Google Scholar
• PLUMED Consortium. (2019). Promoting transparency and reproducibility in enhanced molecular simulations. Nature Methods, 16(8), 670–673.
   PubMed Web of Science ®Google Scholar
• Pustenko, A., Nocentini, A., Gratteri, P., Bonardi, A., Vozny, I., Žalubovskis, R., & Supuran, C. T. (2020). The antibiotic furagin and its derivatives are isoform-selective human carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), 1011–1020. https://doi.org/10.1080/14756366.2020.1752201
   PubMed Web of Science ®Google Scholar
• Roy, A., & Taraphder, S. (2007). Identification of proton-transfer pathways in human carbonic anhydrase II. The Journal of Physical Chemistry. B, 111(35), 10563–10576. https://doi.org/10.1021/jp073499t
   PubMed Web of Science ®Google Scholar
• Roy, A., & Taraphder, S. (2009). Transition path sampling study of the conformational fluctuation of His-64 in human carbonic anhydrase II. The Journal of Physical Chemistry. B, 113(37), 12555–12564. https://doi.org/10.1021/jp9010982
   PubMed Web of Science ®Google Scholar
• Schuetz, D. A., de Witte, W. E. A., Wong, Y. C., Knasmueller, B., Richter, L., Kokh, D. B., Sadiq, S. K., Bosma, R., Nederpelt, I., Heitman, L. H., Segala, E., Amaral, M., Guo, D., Andres, D., Georgi, V., Stoddart, L. A., Hill, S., Cooke, R. M., De Graaf, C., … Ecker, G. F. (2017). Kinetics for drug discovery: An industry-driven effort to target drug residence time. Drug Discovery Today, 22(6), 896–911. https://doi.org/10.1016/j.drudis.2017.02.002
   PubMed Web of Science ®Google Scholar
• Simone, G. D., Alterio, V., & Supuran, C. T. (2013). Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors. Expert Opinion on Drug Discovery, 8(7), 793–810.
   PubMed Web of Science ®Google Scholar
• Spiro, T. G. (1983). Zinc enzymes. Wiley.
   Google Scholar
• Supuran, C., & Nocentini, A. (2019). Carbonic anhydrases: Biochemistry and pharmacology of an evergreen pharmaceutical target. Elsevier Science.
   Google Scholar
• Supuran, C., Scozzafava, A., & Conway, J. (2004). Carbonic anhydrase: Its inhibitors and activators. CRC Press.
   Google Scholar
• Supuran, C. T. (2008). Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nature Reviews. Drug Discovery, 7(2), 168–181. https://doi.org/10.1038/nrd2467
   PubMed Web of Science ®Google Scholar
• Supuran, C. T. (2016). How many carbonic anhydrase inhibition mechanisms exist? Journal of Enzyme Inhibition and Medicinal Chemistry, 31(3), 345–360. https://doi.org/10.3109/14756366.2015.1122001
   PubMed Web of Science ®Google Scholar
• Supuran, C. T. (2017). Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opinion on Drug Discovery, 12(1), 61–88. https://doi.org/10.1080/17460441.2017.1253677
   PubMed Web of Science ®Google Scholar
• Supuran, C. T. (2018). Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas. Expert Opinion on Therapeutic Patents, 28(10), 709–712. https://doi.org/10.1080/13543776.2018.1523897
   PubMed Web of Science ®Google Scholar
• Supuran, C. T. (2020). Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery. Expert Opinion on Drug Discovery, 15(6), 671–686. https://doi.org/10.1080/17460441.2020.1743676
   PubMed Web of Science ®Google Scholar
• Supuran, C. T., & Capasso, C. (2014). Targeting carbonic anhydrases. Future Science Ltd.
   Google Scholar
• Taraphder, S., & Hummer, G. (2003). Protein side-chain motion and hydration in proton-transfer pathways. Results for cytochrome p450cam. Journal of the American Chemical Society, 125(13), 3931–3940.
   PubMed Web of Science ®Google Scholar
• Taraphder, S., Maupin, C. M., Swanson, J. M. J., & Voth, G. A. (2016). Coupling protein dynamics with proton transport in human carbonic anhydrase ii. The Journal of Physical Chemistry. B, 120(33), 8389–8404.
   PubMed Web of Science ®Google Scholar
• Tinivella, A., Pinzi, L., & Rastelli, G. (2021). Prediction of activity and selectivity profiles of human carbonic anhydrase inhibitors using machine learning classification models. Journal of Cheminformatics, 13(1), 18.
   PubMed Web of Science ®Google Scholar
• Torrie, G., & Valleau, J. (1977). Nonphysical sampling distributions in monte carlo free-energy estimation: Umbrella sampling. Journal of Computational Physics, 23(2), 187–199. https://doi.org/10.1016/0021-9991(77)90121-8
   Web of Science ®Google Scholar
• Touisni, N., Maresca, A., McDonald, P. C., Lou, Y., Scozzafava, A., Dedhar, S., Winum, J.-Y., & Supuran, C. T. (2011). Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors. Journal of Medicinal Chemistry, 54(24), 8271–8277. https://doi.org/10.1021/jm200983e
   PubMed Web of Science ®Google Scholar
• Tribello, G. A., Bonomi, M., Branduardi, D., Camilloni, C., & Bussi, G. (2014). Plumed 2: New feathers for an old bird. Computer Physics Communications, 185(2), 604–613. https://doi.org/10.1016/j.cpc.2013.09.018
   Web of Science ®Google Scholar
• Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995). LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Engineering, Design and Selection, 8(2), 127–134. https://doi.org/10.1093/protein/8.2.127
   Web of Science ®Google Scholar
• Wambo, T. O., Chen, L. Y., McHardy, S. F., & Tsin, A. T. (2016). Molecular dynamics study of human carbonic anhydrase II in complex with Zn(2+) and acetazolamide on the basis of all-atom force field simulations. Biophysical Chemistry, 214-215, 54–60. https://doi.org/10.1016/j.bpc.2016.05.006
   PubMed Web of Science ®Google Scholar
• Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general Amber force field. Journal of Computational Chemistry, 25(9), 1157–1174.
   PubMed Web of Science ®Google Scholar
• Wang, Y., Guo, H., Tang, G., He, Q., Zhang, Y., Hu, Y., Wang, Y., & Lin, Z. (2019). A selectivity study of benzenesulfonamide derivatives on human carbonic anhydrase II/IX by 3D-QSAR, molecular docking and molecular dynamics simulation. Computational Biology and Chemistry, 80, 234–243. https://doi.org/10.1016/j.compbiolchem.2019.03.005
   PubMed Web of Science ®Google Scholar
• Wu, Y., Xu, J., Liu, Y., Zeng, Y., & Wu, G. (2020). A review on anti-tumor mechanisms of coumarins. Frontiers in Oncology, 10, 2720. https://doi.org/10.3389/fonc.2020.592853
   Web of Science ®Google Scholar
• Yadav, P. R., Basha, S. H., Satyanarayana, S. D. V., & Pindi, P. K. (2021). Microsecond simulation analysis of carbonic anhydrase-II in complex with (+)-cathechin revealed molecular interactions responsible for its amelioration effect on fluoride toxicity. Journal of Biomolecular Structure and Dynamics, 1–14.
   Web of Science ®Google Scholar
• Yamali, C., Sakagami, H., Uesawa, Y., Kurosaki, K., Satoh, K., Masuda, Y., Yokose, S., Ece, A., Bua, S., Angeli, A., Supuran, C. T., & Gul, H. I. (2021). Comprehensive study on potent and selective carbonic anhydrase inhibitors: Synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1h-pyrazole-1-yl) benzenesulfonamides. European Journal of Medicinal Chemistry, 217, 113351. https://doi.org/10.1016/j.ejmech.2021.113351
   PubMed Web of Science ®Google Scholar
• Yang, C., Feng, Y., Yang, X., Sun, M., Li, Z., Liu, X., Lu, L., Sun, X., Zhang, J., & He, X. (2020). Synthesis and evaluation of 4-(1,3,4-oxadiazol-2-yl)-benzenesulfonamides as potent carbonic anhydrase inhibitors. Bioorganic & Medicinal Chemistry Letters, 30(2), 126874. https://doi.org/10.1016/j.bmcl.2019.126874
   PubMed Web of Science ®Google Scholar